Restates Q3 EPS, Discloses Material Weakness in Internal Controls
GROW sits 20% above its 52-week low of $2.23.
Summary
U.S. Global Investors filed an amended quarterly report to restate its Q3 2026 EPS due to a calculation error and disclosed a material weakness in internal controls over financial reporting.
Key Events · Corporate Governance and Compliance · GROW
-
Q3 2026 EPS Restatement
The company restated its Q3 2026 financial statements, correcting an error in the weighted average number of shares outstanding. This resulted in basic and diluted EPS being overstated by $0.02 for the three months and $0.01 for the nine months ended March 31, 2026.
-
Material Weakness in Internal Controls
Management concluded that disclosure controls and procedures were not effective as of March 31, 2026, due to a material weakness in internal control over financial reporting related to the EPS calculation.
-
Remedial Measures Underway
The company has begun implementing enhanced review procedures and controls to address the identified material weakness, aiming to validate spreadsheet completeness and formula integrity.
Analysis · GROW · Finance
This amended quarterly report formalizes the restatement of Q3 2026 earnings per share, which were previously overstated due to a calculation error. More critically, the company disclosed a material weakness in its internal controls over financial reporting, specifically related to the precision of review controls for EPS calculation. This indicates a significant deficiency in the company's financial reporting processes, which can erode investor confidence in the accuracy and reliability of its financial statements. The company is implementing remedial measures, but the existence of a material weakness is a serious governance concern.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.6% of the 1216 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GROW was trading at $2.67 on NASDAQ in the Finance sector, with a market capitalization of approximately $33.1M. The 52-week trading range was $2.23 to $3.65. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.